Home Institutions NYU Langone Health clinical trials Institution Directory
Clinical trials at NYU Langone Health Sites in New York, NY
Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.
ClinicalTrials.gov public records Last synced Oct 22, 2026, 5:00 PM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official matching trials
1137
Current sort
Recently updated
Campus scope
NYU Langone Health, New York, NY
Additional filters apply within this campus.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Showing 289–300 of 1,137 matching trials with a site at NYU Langone Health, New York, NY.
Live ClinicalTrials.gov results.
Local aggregate panels are unavailable or hidden for filtered views. The result list above identifies its data source.
Live official records
Conditions Prostatic Neoplasms, Castration-Resistant
Interventions Pasritamig, Docetaxel, Prednisone/Prednisolone Drug
Lead sponsor Janssen Research & Development, LLC Industry
Eligibility 18 Years and older
Enrollment 800 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2030
U.S. locations 59
States / cities Chandler, Arizona • Little Rock, Arkansas • Fountain Valley, California + 51 more
Conditions Mitral Regurgitation
Interventions CardioMech MVRS Device
Lead sponsor CardioMech AS Industry
Eligibility 18 Years and older
Enrollment 35 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2021 – 2031
U.S. locations 12
States / cities Thousand Oaks, California • Evanston, Illinois • Wichita, Kansas + 9 more
Conditions Colorectal Neoplasms
Interventions Amivantamab, Cetuximab, 5-fluorouracil, Leucovorin calcium/Levoleucovorin, Oxaliplatin, Irinotecan Hydrochloride Biological · Drug
Lead sponsor Janssen Research & Development, LLC Industry
Eligibility 18 Years and older
Enrollment 1,000 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2032
U.S. locations 81
States / cities Gilbert, Arizona • Jonesboro, Arkansas • Springdale, Arkansas + 67 more
Conditions Squamous Cell Carcinoma of Head and Neck
Interventions Amivantamab, Pembrolizumab, Carboplatin, 5-Flurouracil, Cisplatin Biological · Drug
Lead sponsor Janssen Research & Development, LLC Industry
Eligibility 18 Years and older
Enrollment 500 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2029
U.S. locations 49
States / cities Chandler, Arizona • Tucson, Arizona • Fullerton, California + 43 more
Conditions Stage II Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8, Locally Advanced Rectal Adenocarcinoma
Interventions Capecitabine, 5-fluorouracil, Leucovorin calcium, Irinotecan, Oxaliplatin, Long Course Chemoradiotherapy, Computed Tomography, Magnetic Resonance Imaging, Sigmoidoscopy, biopsy Drug · Radiation · Procedure
Lead sponsor Alliance for Clinical Trials in Oncology Other
Eligibility 18 Years and older
Enrollment 760 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2022 – 2037
U.S. locations 679
States / cities Birmingham, Alabama • Mobile, Alabama • Anchorage, Alaska + 483 more
Conditions Carcinoma, Non-Small-Cell Lung
Interventions Amivantamab, Olomorasib Drug
Lead sponsor Janssen Research & Development, LLC Industry
Eligibility 18 Years and older
Enrollment 60 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2026 – 2029
U.S. locations 2
States / cities New York, New York • Fairfax, Virginia
Conditions Diabetes Mellitus, Type 1
Interventions Insulin icodec, Insulin glargine, Insulin aspart Drug
Lead sponsor Novo Nordisk A/S Industry
Eligibility 18 Years and older
Enrollment 877 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2027
U.S. locations 103
States / cities Cullman, Alabama • Concord, California • Escondido, California + 85 more
Conditions Neurotrophic Keratitis
Interventions Lacripep, Vehicle Ophthalmic Solution Drug · Other
Lead sponsor TearSolutions, Inc. Industry
Eligibility 18 Years and older
Enrollment 54 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2026 – 2027
U.S. locations 6
States / cities Tampa, Florida • Carmel, Indiana • Russells Mills, Massachusetts + 3 more
Conditions Depression
Interventions Active Transcranial Direct Current Stimulation (tDCS), Sham Transcranial Direct Current Stimulation (tDCS) Device
Lead sponsor NYU Langone Health Other
Eligibility 18 Years to 65 Years
Enrollment 100 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2027
U.S. locations 1
States / cities New York, New York
Conditions Metastatic Castration-resistant Prostate Neoplasms, Metastatic Hormone-sensitive Prostate Cancer
Interventions Pasritamig, Cetrelimab, Cabazitaxel, Docetaxel, Apalutamide, Enzalutamide, Darolutamide, Abiraterone acetate plus prednisone (AAP), Lutetium Lu-177 vipivotide tetraxetan, JNJ-101556143 Drug
Lead sponsor Janssen Research & Development, LLC Industry
Eligibility 18 Years and older · Male only
Enrollment 300 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2023 – 2028
U.S. locations 7
States / cities Sarasota, Florida • Grand Rapids, Michigan • St Louis, Missouri + 4 more
Conditions Neoplasms
Interventions JNJ-87704916, Cetrelimab, Standard of Care PD(L)-1 Drug
Lead sponsor Johnson & Johnson Enterprise Innovation Inc. Industry
Eligibility 18 Years and older
Enrollment 126 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2033
U.S. locations 4
States / cities New York, New York • Philadelphia, Pennsylvania • Pittsburgh, Pennsylvania + 1 more
Conditions Breast Cancer
Interventions Predictive Model, Breast Imagers Diagnostic Test
Lead sponsor NYU Langone Health Other
Eligibility 18 Years to 99 Years · Female only
Enrollment 264 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2018 – 2027
U.S. locations 1
States / cities New York, New York About this NYU Langone Health institution page
What this page lists ClinicalTrials.gov records that list NYU Langone Health in New York, NY as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.
Related: all institution pages , browse by condition , or browse by U.S. city .